United States — Food and Drug Administration & Kyle Diamantas
10 shared events · Importance 3 · Last updated Sep 07, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States — Food and Drug Administration: The FDA is the central regulator proposing the new notification requirement and completing the ultraprocessed food definition, enhancing its oversight role.
Kyle Diamantas: As acting FDA Commissioner, Diamantas is the public face of the proposal, articulating its benefits for postmarket safety.
Aug 10, 2026 · 12 articles
Regulatory
United States — Food and Drug Administration: The FDA formalizes cooperation with the SEC, enhancing its role in referring potential securities violations and supporting market integrity, while maintaining confidentiality controls.
Kyle Diamantas: As Acting FDA Commissioner, Diamantas signed the MOU, supporting transparency and cooperation with the SEC.
Aug 31, 2026 · 6 articles
Domestic
United States — Food and Drug Administration: The FDA is the agency being led. It faces staff losses, morale issues, and policy controversies; Overton's nomination could exacerbate these challenges.
Kyle Diamantas: Diamantas has been acting FDA chief since May, providing some stability. His future role is uncertain under a new commissioner.
Aug 19, 2026 · 101 articles
Regulatory
United States — Food and Drug Administration: The FDA is the subject of the restructuring, which could reshape its leadership and regulatory approach, affecting drug approvals and AI oversight.
Kyle Diamantas: Diamantas, acting FDA commissioner, may return to his previous deputy role; his tenure saw reversals on some drug approvals.
Aug 25, 2026 · 6 articles
Accidents
United States — Food and Drug Administration: The FDA led the investigation, linking the outbreak to Taylor Farms lettuce. It faced criticism for a false-positive test result and for potential influence by the United States — White House, but it continues to work on the investigation.
Kyle Diamantas: Acting FDA Commissioner Kyle Diamantas announced the false-positive test result, which complicated the investigation.
Jul 08, 2026 · 358 articles
Regulatory
United States — Food and Drug Administration: The FDA granted approval for mFLUSIVA, marking a regulatory milestone and demonstrating its role in vaccine oversight despite internal controversies.
Kyle Diamantas: As acting FDA Commissioner, Diamantas sought to rebuild industry confidence after the controversies.
Aug 05, 2026 · 105 articles
Regulatory
United States — Food and Drug Administration: The FDA granted expedited approval to daraxonrasib, marking a regulatory milestone and demonstrating its commitment to accelerating cancer treatments. The approval was issued 6.5 months ahead of schedule, reflecting the agency's priority review process.
Kyle Diamantas: As acting FDA Commissioner, Kyle Diamantas announced the approval, emphasizing the agency's duty to deliver treatments quickly, and oversaw the expedited review process.
Aug 26, 2026 · 92 articles
International
Kyle Diamantas: Kyle Diamantas is expected to take over as acting commissioner of the United States — Food and Drug Administration.
Apr 16, 2026 · 760 articles
Domestic
Kyle Diamantas: Kyle Diamantas, the United States — Food and Drug Administration's deputy commissioner for foods, is tasked with developing a definition for 'ultra-processed foods' and is the first non-scientist to head the United States — Food and Drug Administration in over half a century, raising concerns among critics.
May 13, 2026 · 6 articles
Domestic
Kyle Diamantas: Kyle Diamantas will serve as the acting commissioner of the United States — Food and Drug Administration following Marty Makary's resignation, suggesting a potential shift in the agency's approach to various regulatory issues.
May 08, 2026 · 114 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Kyle Diamantas interact across events, view sentiment trends, and discover connected entities.
Open Dashboard